This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1073858408327809v1 15/3/243    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Meller, R. Search for Related Content PubMed PubMed Citation Articles by Meller, R. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance

RS Dow Neurobiology Laboratories, Cancer Research Laboratories, Legacy Clinical Research and Technology Center, Portland, Oregon

^* To whom correspondence should be addressed. E-mail: rmeller{at}downeurobiology.org.

	Abstract

Ubiquitin modification targets a protein for rapid degradation by the proteasome. However, polyubiquitination of proteins can result in multiple functions depending on the topology of the ubiquitin chain. Therefore, ubiquitin signaling offers a more complex and versatile biology compared with many other posttranslational modifications. One area of potential for the application of this knowledge is the field of ischemia-induced brain damage, as occurs following a stroke. The ubiquitin proteasome system may exert a dual role on neuronal outcome following ischemia. Harmful ischemia results in an overload of the ubiquitin proteasome system, and blocking the proteasome reduces brain infarction following ischemia. However, the rapid and selective degradation of proteins following brief ischemia results in endogenous protection against ischemia. Therefore, further understanding of the molecular signaling mechanisms that regulate the ubiquitin proteasome system may reveal novel therapeutic targets to reduce brain damage when ischemia is predicted or reduce the activation of the cell death mechanisms and the inflammatory response following stroke. The aim of this review is to discuss some of the recent advances in the understanding of protein ubiquitination and its implications for novel stroke therapies.

First published on January 30, 2009, doi:10.1177/1073858408327809

The Neuroscientist 2009;15:243.

A more recent version of this article appeared on June 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?